High-dimensional single-cell analyses have improved the ability to resolve complex mixtures of cells from human disease samples; however, identifying disease-associated cell types or cell states in patient samples remains challenging because of technical and interindividual variation. Here, we present mixed-effects modeling of associations of single cells (MASC), a reverse single-cell association strategy for testing whether case-control status influences the membership of single cells in any of multiple cellular subsets while accounting for technical confounders and biological variation. Applying MASC to mass cytometry analyses of CD4⁺ T cells from the blood of rheumatoid arthritis (RA) patients and controls revealed a significantly expanded population of CD4⁺ T cells, identified as CD27⁻ HLA-DR⁺ effector memory cells, in RA patients (odds ratio, 1.7; P = 1.1 × 10⁻³). The frequency of CD27⁻ HLA-DR⁺ cells was similarly elevated in blood samples from a second RA patient cohort, and CD27⁻ HLA-DR⁺ cell frequency decreased in RA patients who responded to immunosuppressive therapy. Mass cytometry and flow cytometry analyses indicated that CD27⁻ HLA-DR⁺ cells were associated with RA (meta-analysis P = 2.3 × 10⁻⁴). Compared to peripheral blood, synovial fluid and synovial tissue samples from RA patients contained about fivefold higher frequencies of CD27⁻ HLA-DR⁺ cells, which comprised ~10% of synovial CD4⁺ T cells. CD27⁻ HLA-DR⁺ cells expressed a distinctive effector memory transcriptomic program with T helper 1 (TH1)- and cytotoxicity-associated features and produced abundant interferon-γ (IFN-γ) and granzyme A protein upon stimulation. We propose that MASC is a broadly applicable method to identify disease-associated cell populations in high-dimensional single-cell data.
No takes yet. Share an insight, caveat, or question.
Fonseka et al. (2018) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: